These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22011971)

  • 1. Predictive factors of bacteraemia in low-risk patients with febrile neutropenia.
    Ahn S; Lee YS; Chun YH; Lim KS; Kim W; Lee JL
    Emerg Med J; 2012 Sep; 29(9):715-9. PubMed ID: 22011971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Procalcitonin for early diagnosis of bacteraemia in children with cancer].
    Chawes BL; Rechnitzer C; Schmiegelow K; Tvede M
    Ugeskr Laeger; 2007 Jan; 169(2):138-42. PubMed ID: 17227662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients.
    Erten N; Genc S; Besisik SK; Saka B; Karan MA; Tascioglu C
    J Chin Med Assoc; 2004 May; 67(5):217-21. PubMed ID: 15357107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10.
    Uys A; Rapoport BL; Fickl H; Meyer PW; Anderson R
    Eur J Cancer Care (Engl); 2007 Nov; 16(6):475-83. PubMed ID: 17944761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia].
    Fu Y; Jiang H; Li LX; Chen J; Zhang JL; Wang LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1296-300. PubMed ID: 24156453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial procalcitonin levels to detect bacteremia in febrile neutropenia.
    Reitman AJ; Pisk RM; Gates JV; Ozeran JD
    Clin Pediatr (Phila); 2012 Dec; 51(12):1175-83. PubMed ID: 23034950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
    von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
    Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant].
    Sánchez-Yepes M; Aznar-Oroval E; Lorente-Alegre P; García-Lozano T; Picón-Roig I; Pérez-Ballestero P; Ortiz-Muñoz B
    Enferm Infecc Microbiol Clin; 2014; 32(7):418-23. PubMed ID: 24269102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia.
    Urbonas V; Eidukaitė A; Tamulienė I
    Cytokine; 2013 Apr; 62(1):34-7. PubMed ID: 23510625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.
    Yang M; Choi SJ; Lee J; Lee DG; Kim YJ; Park YJ; Oh EJ
    PLoS One; 2019; 14(12):e0225765. PubMed ID: 31821331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever.
    Chirouze C; Schuhmacher H; Rabaud C; Gil H; Khayat N; Estavoyer JM; May T; Hoen B
    Clin Infect Dis; 2002 Jul; 35(2):156-61. PubMed ID: 12087521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia.
    Giamarellos-Bourboulis EJ; Grecka P; Poulakou G; Anargyrou K; Katsilambros N; Giamarellou H
    Clin Infect Dis; 2001 Jun; 32(12):1718-25. PubMed ID: 11360214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients.
    Vänskä M; Koivula I; Jantunen E; Hämäläinen S; Purhonen AK; Pulkki K; Juutilainen A
    Cytokine; 2012 Dec; 60(3):787-92. PubMed ID: 22902948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia.
    Persson L; Engervall P; Magnuson A; Vikerfors T; Söderquist B; Hansson LO; Tidefelt U
    Scand J Infect Dis; 2004; 36(5):365-71. PubMed ID: 15287382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia.
    Ahn S; Lee YS; Lim KS; Lee JL
    Support Care Cancer; 2013 Aug; 21(8):2303-8. PubMed ID: 23519568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia.
    Jimeno A; García-Velasco A; del Val O; González-Billalabeitia E; Hernando S; Hernández R; Sánchez-Muñoz A; López-Martín A; Durán I; Robles L; Cortés-Funes H; Paz-Ares L
    Cancer; 2004 Jun; 100(11):2462-9. PubMed ID: 15160353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia.
    Koivula I; Hämäläinen S; Jantunen E; Pulkki K; Kuittinen T; Nousiainen T; Juutilainen A
    Scand J Infect Dis; 2011 Jul; 43(6-7):471-8. PubMed ID: 21299364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin in the assessment of bacteraemia in emergency department patients: results of a large retrospective study.
    Kim SY; Jeong TD; Lee W; Chun S; Min WK
    Ann Clin Biochem; 2015 Nov; 52(Pt 6):654-9. PubMed ID: 25575698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.
    Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.